Lymph leakage promotes insulin resistance in obesity

Affiliations

Comment

Anna Kriebs. Nat Rev Endocrinol. 2021 Dec.

. 2021 Dec;17(12):708.

doi: 10.1038/s41574-021-00588-w.

No abstract available

Comment on

Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity.
Cao E, Watt MJ, Nowell CJ, Quach T, Simpson JS, De Melo Ferreira V, Agarwal S, Chu H, Srivastava A, Anderson D, Gracia G, Lam A, Segal G, Hong J, Hu L, Phang KL, Escott ABJ, Windsor JA, Phillips ARJ, Creek DJ, Harvey NL, Porter CJH, Trevaskis NL. Cao E, et al. Nat Metab. 2021 Sep;3(9):1175-1188. doi: 10.1038/s42255-021-00457-w. Epub 2021 Sep 20. Nat Metab. 2021. PMID: 34545251

1. Cao, E. et al. Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity. Nat. Metab. https://doi.org/10.1038/s42255-021-00457-w (2021) - DOI - PubMed - PMC